These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 6999984)
21. Bactericidal activity of ciprofloxacin in serum and urine against Escherichia coli, Pseudomonas aeruginosa, Klebsiella pneumoniae, Staphylococcus aureus and Streptococcus faecalis. Lagast H; Husson M; Klastersky J J Antimicrob Chemother; 1985 Sep; 16(3):341-7. PubMed ID: 2932416 [TBL] [Abstract][Full Text] [Related]
22. Serum sensitivity and cell surface hydrophobicity of Klebsiella pneumoniae treated with gentamicin, tobramycin and amikacin. Hostacká A J Basic Microbiol; 1998; 38(5-6):383-8. PubMed ID: 9871334 [TBL] [Abstract][Full Text] [Related]
23. In-vitro antibacterial effect of tea polyphenols combined with common antibiotics on multidrug-resistant Klebsiella pneumoniae. Zhang N; Liu W; Qian K Minerva Med; 2020 Dec; 111(6):536-543. PubMed ID: 32340432 [TBL] [Abstract][Full Text] [Related]
24. Effects of subinhibitory concentrations of moxifloxacin in an in-vitro dynamic model. Maggiolo F; Capra R; Bartoli A; Bottura P; Migliorino M; Suter F J Chemother; 2000 Apr; 12(2):129-33. PubMed ID: 10789551 [TBL] [Abstract][Full Text] [Related]
25. Effect of concentration on bactericidal activity of cefotaxime. Shah PM; Troche G; Stille W J Antimicrob Chemother; 1979 Jul; 5(4):419-22. PubMed ID: 114510 [No Abstract] [Full Text] [Related]
26. Bactericidal activity of ertapenem against major intra-abdominal pathogens. Borbone S; Cascone C; Santagati M; Mezzatesta ML; Stefani S Int J Antimicrob Agents; 2006 Nov; 28(5):396-401. PubMed ID: 17045463 [TBL] [Abstract][Full Text] [Related]
27. [In vitro activity of cefoxitin, a new cephalosporin (author's transl)]. Shah PM; Zwischenbrugger H; Stille W MMW Munch Med Wochenschr; 1976 Nov; 118(45):1469-72. PubMed ID: 825763 [TBL] [Abstract][Full Text] [Related]
28. In vitro bactericidal action of cefoperazone, cefoxitin, cefuroxime, cefazolin and cephaloridine. Piantieri G; Cafarelli A; Magliulo E G Batteriol Virol Immunol; 1981; 74(1-6):15-25. PubMed ID: 6458524 [No Abstract] [Full Text] [Related]
29. Antibacterial activity and kill kinetics of amoxicillin-clavulanic acid combinations against Escherichia coli and Klebsiella aerogenes. Fuglesang JE; Bergan T Infection; 1983; 11(6):329-35. PubMed ID: 6365790 [TBL] [Abstract][Full Text] [Related]
30. FCE 22101 and FCE 22891: in-vitro antibacterial activity at concentrations simulating human plasma levels following intravenous, intramuscular and oral administration. Della Bruna C; Jabes D; Rossi R; Younes G; Castellani P J Antimicrob Chemother; 1989 Mar; 23 Suppl C():119-28. PubMed ID: 2659570 [TBL] [Abstract][Full Text] [Related]
31. [Bactericidal activity of antibiotics as a function of pharmacokinetic constants. II. Effect of pharmacokinetic parameters (C max and Ke) on the bactericidal activity of gentamicin]. Drugeon HB; Maurisset B; Chung SS; Courtieu AL Pathol Biol (Paris); 1982 Dec; 30(10):840-2. PubMed ID: 6760060 [TBL] [Abstract][Full Text] [Related]
32. [Comparison between the activity of 2 amino-glycoside antibiotics, tobramycin and gentamicin on gram negative bacteria in vitro]. De Rosa F; Tassi C; Stagni GR Ann Sclavo; 1974; 16(1):65-72. PubMed ID: 4214247 [No Abstract] [Full Text] [Related]
34. Fluoroquinolone resistance in Escherichia coli and Klebsiella pneumoniae over 18 years: effect of different systems for eliminating duplicates. Noguera O; López-Riquelme N; Rodríguez JC; Belda S; Galiana A; Ruiz-García M; López-García P; Royo G J Antimicrob Chemother; 2011 Sep; 66(9):2182-4. PubMed ID: 21693462 [No Abstract] [Full Text] [Related]
35. Prevalent phenotypes and antibiotic resistance in Escherichia coli and Klebsiella pneumoniae at an Indian tertiary care hospital: plasmid-mediated cefoxitin resistance. Shahid M; Malik A; Akram M; Agrawal LM; Khan AU; Agrawal M Int J Infect Dis; 2008 May; 12(3):256-64. PubMed ID: 17981482 [TBL] [Abstract][Full Text] [Related]
36. [Use of the materials based on partially reduced graphene-oxide with silver nanoparticle as bacteriostatic and bactericidal agent]. Kedziora A; Gerasymchuk Y; Sroka E; Bugla-Płoskońska G; Doroszkiewicz W; Rybak Z; Hreniak DC; Wilgusz R; Strek WA Polim Med; 2013; 43(3):129-34. PubMed ID: 24377177 [TBL] [Abstract][Full Text] [Related]
37. [In vitro bactericidal activities of new oral penem, faropenem against the various clinical isolates]. Matsuzaki K; Nishiyama T; Hasegawa M; Kobayashi I; Kaneko A; Sasaki J Jpn J Antibiot; 1999 May; 52(5):431-8. PubMed ID: 10480050 [TBL] [Abstract][Full Text] [Related]
38. Minimum inhibitory and bactericidal concentrations of 44 antimicrobial agents against three standard control strains in broth with and without human serum. Reimer LG; Stratton CW; Reller LB Antimicrob Agents Chemother; 1981 Jun; 19(6):1050-5. PubMed ID: 6791584 [TBL] [Abstract][Full Text] [Related]
39. Synthesis and characterization of the antibacterial potential of ZnO nanoparticles against extended-spectrum β-lactamases-producing Escherichia coli and Klebsiella pneumoniae isolated from a tertiary care hospital of North India. Ansari MA; Khan HM; Khan AA; Sultan A; Azam A Appl Microbiol Biotechnol; 2012 Apr; 94(2):467-77. PubMed ID: 22159886 [TBL] [Abstract][Full Text] [Related]
40. Bacteriostatic and bactericidal activities of selected beta-lactam antibiotics studied on agar plates. Masuda G; Tomioka S; Uchida H; Hasegawa M Antimicrob Agents Chemother; 1977 Mar; 11(3):376-82. PubMed ID: 855996 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]